Bilateral synchronous papillary renal neoplasm with reverse polarity and renal cell carcinoma with fibromyomatous stroma: a case report and review of the literature

双侧同步性乳头状肾肿瘤伴反极性及纤维肌瘤样间质肾细胞癌:病例报告及文献复习

阅读:1

Abstract

BACKGROUND: This report presents an exceptionally rare case of bilateral synchronous renal tumors comprising papillary renal neoplasm with reverse polarity (PRNRP) and renal cell carcinoma with fibromyomatous stroma (RCC-FMS) in a single patient. No prior cases of this specific combination occurring synchronously and bilaterally have been reported. CASE PRESENTATION: A 65-year-old man presented with incidentally detected bilateral renal masses. Abdominal ultrasound and contrast-enhanced computed tomography (CT) revealed distinct imaging characteristics for each tumor. The right kidney mass was exophytic, heterogeneous, and hypovascular on ultrasound, showing marked heterogeneous enhancement with hypoenhancing foci on CT. The left kidney mass was a well-circumscribed, mixed-attenuation nodule with peripheral/septal enhancement on CT. The patient underwent bilateral laparoscopic partial nephrectomy. Histopathological and immunohistochemical analysis confirmed PRNRP in the right kidney (CK7+, GATA3+, Ki-67 approximately 2%) and RCC-FMS in the left kidney (PAX-8+, CA IX+, CD10+, Ki-67 approximately 3%). Real-time quantitative-PCR testing was positive for a KRAS exon 2 mutation, but was negative for NRAS (exons 2-4) and BRAF V600 (exon 15) mutations. CONCLUSION: This represents the first documented case of synchronous bilateral occurrence of PRNRP and RCC-FMS. It highlights significant diagnostic challenges due to overlapping imaging features with more common renal tumors. It underscores the critical role of multimodal imaging (ultrasound, CT) combined with meticulous histopathology, immunohistochemistry, and molecular genetic analysis for accurate diagnosis. The generally indolent nature of both tumors supported successful nephron-sparing surgical management. This unique case emphasizes the need for a high index of suspicion for rare tumor subtypes and a multidisciplinary approach to optimize the diagnosis and tailored treatment of complex renal masses.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。